• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC121200
Device Problems Detachment Of Device Component (1104); Unintended Collision (1429); Retraction Problem (1536); Physical Resistance (2578); Difficult to Advance (2920)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/18/2015
Event Type  Injury  
Event Description
On (b)(6) 2015, the patient was implanted with gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.The patient reportedly had tortuous anatomy.It was reported the physician elected to canulate the contralateral gate ¿bareback¿.A cook 12fr sheath was being used for the procedure.The physician was attempting to canulate the contralateral gate and felt some resistance and the device got caught on something.However, he was able to canulate the gate and successfully deploy the device.Upon retracting the delivery catheter the physician noticed the olive had become separated from the delivery device, he snared the olive to remove it from the patient.The olive was removed from the patient, and the procedure concluded with no further issue.The patient tolerated the procedure.
 
Manufacturer Narrative
Medications: multivitamins, advair, cozaar, furosemide, vitamin d, glucotrol, hydrochlorothiazide, januvia, detrol, zocor, and metoprolol.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
The device was returned to gore for evaluation, per gore engineering the evaluation revealed the guidewire was not returned, therefore unavailable for engineering evaluation.The returned product showed that the polyimide guidewire lumen detachment at the leading end of the trailing olive junction.Based on the available information and evaluation of the returned portion of the product, no root cause could be determined at this time.However, use outside of the ifu was noted and may have contributed to this event.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), the warnings and precautions section of the ifu states: ¿warning: do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.¿ the warnings and precautions section of the ifu also states, ¿do not attempt to withdraw any undeployed endoprosthesis through the 12 fr, 18 fr or 20 fr introducer sheath.The sheath and catheter must be removed together.¿ further the ifu states, ¿do not continue advancing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
rachael chascsa
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4846335
MDR Text Key5812865
Report Number2953161-2015-00062
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2016
Device Catalogue NumberPXC121200
Device Lot Number11689680
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/22/2015
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/13/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
Patient Weight77
-
-